Low CXCL12 expression restrained glycolytic reprogramming and indirectly promoted aerobic glycometabolism might become one of the possible mechanisms for low CXCL12 expression inducing poor AML prognosis. The gene discussed is CXCL12; the disease is acute myeloid leukemia.